Who is sponsoring NCT04934904?

NCT04934904 is sponsored by Zhujiang Hospital.

What condition does NCT04934904 study?

NCT04934904 studies Gastrointestinal Disease.

What drugs are being tested in NCT04934904?

Interventions: Ropivacaine injection.

What is the status of NCT04934904?

NCT04934904 is currently COMPLETED.

Last reviewed 2022-09-09 · How we verify

The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block

NCT04934904 NA COMPLETED

In this single-center, randomized, parallel control clinical trial, patients will be randomly assigned to two groups. The treatment group receives ultrasound-guided erector spinae plane block with routine treatment of Acute Gastrointestinal Injury (AGI) for 7 days or until transferred to the general ward, while the control group only receives routine treatment of AGI. The primary outcome is the cure and remission rate of AGI.

Details

Lead sponsor	Zhujiang Hospital
Phase	NA
Status	COMPLETED
Enrolment	100
Start date	Thu Aug 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Sep 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Gastrointestinal Disease

Interventions

Ropivacaine injection

Countries

China